Click here to invite colleagues to join the Forum for FREE   Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact CVD prevention in the last 12 months A momentous year in cardiology Last year saw exciting developments in the prevention of cardiovascular (CV) disease. This was the year that PCSK9 inhibitors became available for clinical use in the USA, Europe and elsewhere. From data presented and published in 2015 the ability of these innovative agents to reduce LDL-cholesterol to new levels was clearly established. And, for the first time, studies pointed to consequent reductions in CV outcomes, setting the scene for the year to come. In a review of the year, Professor John Chapman and co-authors discuss these and other important events. Read full report » Forward to colleagues » Chapman MJ, Blankenberg S, Landmesser U. The year in cardiology 2015: prevention. Eur Heart J. 2016 Jan 3. pii: ehv721. [Epub ahead of print] Editors choice Forum editors select some of the key developments in the last 12 months: 1   The promise of PCSK9 inhibition may deliver in reducing cardiovascular outcomes. 2 & 3   Meta-analyses provide further evidence of cardiovascular benefit and reassurance on safety. 4   Reassurance on effects of PCSK9 inhibition on vitamin E and steroid hormone levels. 5 & 6   Familial hypercholesterolaemia (FH, inherited high cholesterol) has finally received much warranted attention. 7   Largest dataset of heterozygous FH patients treated with a PCSK9 inhibitor (ODYSSEY programme). 8   Norwegian registry study clearly shows that even in the post-statin era, FH is undertreated. 9   IMPROVE-IT: a landmark study 10   Concluding the Top 10 parade is the timely up to date PCSK9 review from the Editors, free to download from PCSK9 Forum. Read full report » Questions & Answers Millions of people who suffer with hypercholesterolaemia remain at a high risk of premature death, despite current treatment. Read the full answer and other questions on the PCSK9 Forum » Free e-book Understanding PCSK9 inhibition For healthcare professionals Prepared by independent experts from PCSK9 Education and Research Forum. Register and read online »    Download now » Like us on Facebook For the latest updates, PCSK9 news and analysis. Follow us on Twitter Hot topics, news and conference reports. YouTube Channel For videos, interviews and webcasts from leading experts. Educational Partners and Supporters Copyright PCSK9 Forum 2016. Please click here to unsubscribe from future mailings.